echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > PD-1 antibody "new partner": fusion of IL-21 has greatly improved anti-tumor efficacy

    PD-1 antibody "new partner": fusion of IL-21 has greatly improved anti-tumor efficacy

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     

    png">

    png">

     

    PD-1 inhibitors can restore the vitality of bioon.


    bioon.


    bioon.


    bioon.


    The researchers observed that PD-1AB21 completely blocked the binding of PD-L1IgFc after binding to EG7 lymphoma cells expressing PD-1 and activated CD8+ T cells.


    This indicates that PD-1AB21 can bind to PD-1 on activated T cells, blocking the interaction of PD-1 and PD-L1, while maintaining the biological activity of IL-21.


    After in-depth exploration, the researchers found that PD-1Ab21 can target IL-21 to activated T cells, and compared to recombinant IL-21, it can more effectively induce activated CD8+ T cells to differentiate into TSCM cells (memory stem T cells).


    TSCM cells have strong proliferation potential, long-term survival ability and the ability to generate all memory and effector T cell subsets after exposure to antigen.


    Tumor-bearing mice showed an increase in the frequency of TSCM and a large number of tumor-specific memory T cells after PD-1AB21 treatment, and the anti- bioon.


    bioon.


    bioon.


    bioon.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.